Silence of the genes: the relation between gene methylation and its expression.

Methylation as an epigenetic mechanism

At its core, DNA methylation is an epigenetic mechanism that involves the addition of methyl groups to cytosine residues in DNA, thereby affecting gene expression without altering the nucleotide sequence itself (see Figure 1). The methyl group creates a barrier, over which the transcription mechanisms, such as RNA polymerase, have difficulties progressing. This is especially true when promotor regions of genes are methylated. Thus, more methylation (hypermethylation) essentially silences the gene, while no methylation (hypomethylation) would allow the gene to be transcribed and expressed.
Methylation plays a big role in the gene regulation during e.g. embryonic development, regulating the moment when which gene needs to be activated. However, in most fully grown organisms, methylation still plays a dynamic role where genes can be methylated or demethylated depending on the cellular needs, maintaining cellular function and identity. Additionally, the role of non-coding RNAs in epigenetic regulation highlights the complexity of gene expression control. These molecules, which do not code for proteins, can influence gene activity through mechanisms such as RNA interference and the modulation of chromatin structure.
Different methylation patterns in normal (A) and malignant (B) cells.
Figure 1: Different methylation patterns in normal (A) and malignant (B) cells. Cancer cells can exhibit global hypomethylation of the genome accompanied by region-specific hypermethylation. Figure copied from Wentzel & Pretorius, 2012 1.

Faulty methylation patterns

Aberrant methylation patterns are a hallmark of many cancers through inappropriate silencing of tumor suppressors or expression of oncogenes, thus contributing to the development of disease states 2. A recent multi-omic study 3. investigating methylation patterns of 687 tumor profiles found several clear hyper- and hypo-methylated regions that can be linked to specific cancer types. For instance, prostate cancer can be linked to novel epigenomic subtypes associated with hypermethylation and somatic mutations in TET2, DNMT3B, IDH1, and BRAF 4. Interestingly, this was discovered using whole-genome, whole-methylome, and whole-transcriptome sequencing. This makes sense, if one wants to truly understand cancer, one must look for different expression patterns and its genomic of epigenomic causes. Understanding these mechanisms could open new avenues for therapeutic interventions, where modulating DNA methylation patterns could restore normal gene function.

Investigating DNA methylation

Methylation patterns in genomes are discovered through a spectrum of techniques ranging from gene-specific approaches to whole-genome analyses. Initially, methods like bisulfite sequencing have been pivotal, offering precise detection of methylated cytosines in individual genes. Moving towards a broader scope, technologies like Reduced Representation Bisulfite Sequencing (RRBS) focussed on CpG-rich regions, providing insights into methylation patterns across specific genomic loci. Advancements in microarray-based methods, such as Methylated DNA Immunoprecipitation Sequencing (MeDIP-seq) and Methyl-CpG binding domain sequencing (MBD-seq), enabled genome-wide methylome profiling, capturing methylated DNA fragments for analysis. Additionally, whole-genome bisulfite sequencing (WGBS) offered comprehensive coverage of methylation patterns across the entire genome.
Long-read sequencing utilizing nanopore technology has emerged as a breakthrough, sequencing genomic and epigenomic (bimodal) data at single-molecule resolution at the same time. This revolutionary approach facilitates discernment of genomic and epigenomic underpinnings of diseases like cancer, offering unprecedented insights into their etiology and progression. Combined with a transcriptome analysis using long-read sequencing, one can combine the (epi)genomic data with expression. Notably, even RNA methylation can be investigated using long-read sequencing 5. , adding an additional layer of information to the investigation.
Using Nanopore sequencing to detect modified bases (DNA or RNA) using a difference in current.
Figure 2: Using Nanopore sequencing to detect modified bases (DNA or RNA) using a difference in current. Machine Learning algorithms are trained to interpret differences in currents while at the same time keeping information on genomic data. These algorithms can be trained for several, if not all, possible base modifications. Figure adapted from Xu & Seki 2020 6.

The OHMX.bio approach

OHMX.bio has a specialty lab focused on several sequencing solutions. This includes both short- and long-read sequencing with a goal to provide a one-stop solution for your research. OHMX.bio can combine genomic and epigenomic data, sequenced in-house, with transcriptomic and even translatomic and proteomic data. This means OHMX.bio can provide complete information about the pathway of a gene, from its exact genetic code (and mutations) to its regulation, expression, and translation.
The advantage of using one lab to perform all analyses, in a pick-and-mix fashion, is the guarantee that all samples are processed within the same quality system, by the same experts. This leads to fewer logistic errors and paperwork and allows for clear answers. Whether it is for oncological research or biomarker discovery, OHMX.bio can help.

References

[1] Wentzel, Jaco & Pretorius, Piet. (2012). Investigating the Role DNA Methylations Plays in Developing Hepatocellular Carcinoma Associated with Tyrosinemia Type 1 Using the Comet Assay. 10.5772/2159.
[2] Lakshminarasimhan R, Liang G. The Role of DNA Methylation in Cancer. Adv Exp Med Biol. 2016;945:151-172. doi: 10.1007/978-3-319-43624-1_7. PMID: 27826838; PMCID: PMC7409375.
[3] Wen-Wei Liang et. al. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin, Cancer Cell, 41, 9, 2023:1567-1585.e7, ISSN 1535-6108, https://doi.org/10.1016/j.ccell.2023.07.013.
[4] Zhao, S.G., Chen, W.S., Li, H. et al. The DNA methylation landscape of advanced prostate cancer. Nat Genet 52, 778–789 (2020). https://doi.org/10.1038/s41588-020-0648-8
[5] An, Y., Duan, H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer 21, 14 (2022). https://doi.org/10.1186/s12943-022-01500-4
[6] Xu, L., Seki, M. Recent advances in the detection of base modifications using the Nanopore sequencer. J Hum Genet 65, 25–33 (2020). https://doi.org/10.1038/s10038-019-0679-0

Search all posts

Popular news & events

Tags

Do you have questions about DNA methylation?

Fill out the form below and our experts will get back to you as soon as possible!
Logo-OHMX.bio
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Cookie statement

Last updated:  19-09-2024

This cookie statement is drafted and managed by OHMX.bio NV,

hereafter referred to as “OHMX.bio”.

OHMX.bio has its headquarters at Proeftuinstraat 86, 9000 Gent, Belgium, registered with company number XXX.

For all questions and/or remarks, please contact us at the address mentioned above or at the e-mail address privacy@ohmx.bio.

USE OF COOKIES

 

OHMX.bio considers it important that you can view, listen to, read or experience our website content at any place and at any time via various media platforms. We want you to be able to use interactive features and provide services tailored to your needs. Therefore OHMX.BIO uses online techniques like cookies, scripts and similar technologies (hereafter referred to as ‘cookies’). These help us facilitate the use of the website and improve its functionality, by collecting (personal) data of our website visitors via their website usage.

 

In this cookie statement, OHMX.bio wishes to inform you what kind of cookies are used and why.

OHMX.bio can amend the cookie statement at any time. This can happen, for example, in the context of changes to its services or the applicable legislation. The amended statement will then be published on the OHMX.bio websites and will apply from the moment it is published.

 

If the use of certain cookies also involves the processing of “personal data”, the OHMX.bio Privacy Statement is also applicable.

 

WHAT ARE COOKIES?

 

A cookie is a small data file that is installed in the browser of your computer or mobile device by a website's server or application when you visit a website or use a (mobile) application.

The cookie file contains a unique code with which your browser can be recognized during the visit to the online service or during consecutive, repeated visits. They generally make the interaction between the visitor and the website or application easier and faster and help the visitor to navigate between the different parts of a website or application. They allow us to retain certain settings, such as your language choice or to optimize your user experience.

 

There are different types of cookies that can be distinguished according to their origin, function and lifespan. This is explained further in the next section.

TYPES OF COOKIES

How long are cookies stored?

Cookies can be stored on your computer or mobile device for different periods of time. Depending on the type, they (and the information they collect) are automatically deleted when you close your browser (these are the so-called “session cookies”), in other cases, these remain stored for a longer period of time and can also be used during a subsequent visit to this website (these are the so-called “permanent cookies”).

Consult the detailed information on OHMX.bio cookies (below) to know the retention periods.

Who places and manages cookies?

First-party cookies

First-party cookies are managed by OHMX.bio and are specific to the visited or used online service.

Third party cookies

Third party cookies are managed and placed by a third party. This happens during your visit or use of the website. These ensure that certain information is sent to third parties by your visit to the website.

Why cookies?

Necessary cookies

Necessary or essential cookies are necessary for the operation of the website. It is therefore advised not to disable these.

Functional cookies

These are cookies that ensure that the website functions properly. Examples of some functions performed:

- remembering your login details

- ensuring the security of your login details

- ensuring the uniformity of the layout of the website

Performance and analysis cookies

On the basis of these cookies, information is collected about the way visitors use our website. This is done with the intention to improve the content of our websites, to further adapt it to the wishes of the visitors and to increase the usability of our websites. Like for example google analytics.

Social media cookies

The website can implement so-called embedded elements of other third parties, such as YouTube, Twitter and Facebook. These are used to integrate social media into the website via plug-ins.

Other cookies

These are cookies that do not belong to one of the above categories. For example, cookies that can be used to make web analyzes themselves to optimize the website. In addition to the above-mentioned performance and analysis cookies, other web analysis cookies can be used. These will probably have to be disabled because identifiable personal data may be processed here. This is not the case with the mentioned performance analysis cookies.

OHMX.bio  uses different types of cookies.

 

Cookie Description Duration Type
cookielawinfo-checkbox-necessary This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". 1 hour Necessary
__utma This cookie is set by Google Analytics and is used to distinguish users and sessions. The cookie is created when the JavaScript library executes and there are no existing __utma cookies. The cookie is updated every time data is sent to Google Analytics. 2 years Performance
__utmc The cookie is set by Google Analytics and is deleted when the user closes the browser. The cookie is not used by ga.js. The cookie is used to enable interoperability with urchin.js which is an older version of Google analytics and used in conjunction with the __utmb cookie to determine new sessions/visits. Performance
__utmz This cookie is set by Google analytics and is used to store the traffic source or campaign through which the visitor reached your site. 5 months Performance
__utmt The cookie is set by Google Analytics and is used to throttle request rate. 10 minutes Performance
__utmb The cookie is set by Google Analytics. The cookie is used to determine new sessions/visits. The cookie is created when the JavaScript library executes and there are no existing __utma cookies. The cookie is updated every time data is sent to Google Analytics. 30 minutes Performance

 

HOW CAN YOU TURN OFF COOKIES?

 

If you choose to disable cookies, you can do so for the browser you use:

 

If you use different devices to visit this website, make sure that your cookie preferences are set on the browser of every device.

 

Please note that disabling certain cookies may result in the malfunction of related features on the website e.g. certain graphics may not show the way they are meant to, or you may not be able to use certain services.

CHANGES TO THIS COOKIE STATEMENT

OHMX.BIO may amend this Cookie Statement in accordance with certain technical, legal or commercial requirements and developments. We will inform you accordingly, taking into account the importance of the changes that have been made. You may find the date on which this Cookie Statement was last modified at the top of this Cookie Statement.